Images in cardiovascular medicine. Rapid dissolution of massive intracoronary thrombosis with platelet glycoprotein IIb/IIIa receptor inhibitor
Rerkpattanapipat, P.; Kotler, M.N.; Yazdanfar, S.
Circulation 99(22): 2965
1999
ISSN/ISBN: 0009-7322 PMID: 10359744 Document Number: 498038
Document emailed within 1 workday
Related Documents
Coller, B.S.; Lang, D.; Scudder, L.E. 1997: Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade Circulation 95(4): 860-867Kitagawa, H.; Yamamoto, N.; Yamamoto, K.; Tanoue, K.; Kosaki, G.; Yamazaki, H. 1989: Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells Cancer Research 49(3): 537-541
Coto, H. 2000: Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab Journal of Invasive Cardiology 12(10): 528-531
Tarantini, G.; Cardaioli, P.; Chioin, R. 2001: Images in cardiovascular medicine. Coronary spasm resistant to intracoronary nitrates following successful stent implantation Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2(11): 858-859
White, H.D. 2000: Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies? Journal of Invasive Cardiology 12 Suppl A: 6a
Abu-Amero, K.K.; Wyngaard, C.A.; Dzimiri, N. 2004: Association of the platelet glycoprotein receptor IIIa (PlA1/PlA1) genotype with coronary artery disease in Arabs Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 15(1): 77-79
Rübsamen, K.; Hornberger, W.; Kirchengast, M. 1995: Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857 Thrombosis and Haemostasis 74(5): 1353-1360
Mak, K.H.; Kottke-Marchant, K.; Brooks, L.M.; Topol, E.J. 1998: In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia Thrombosis and Haemostasis 80(6): 989-993
Müller, T.H.; Weisenberger, H.; Brickl, R.; Narjes, H.; Himmelsbach, F.; Krause, J. 1997: Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men Circulation 96(4): 1130-1138
Caputo, R.P.; Giambartolomei, A.; Simons, A.; Reger, M.; Wagner, S.; Esente, P. 2001: Adjunctive therapies in the cath lab. use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia Journal of Invasive Cardiology 13(9): 657-660
Collen, D.; Lu, H.R.; Stassen, J.M.; Vreys, I.; Yasuda, T.; Bunting, S.; Gold, H.K. 1994: Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis Thrombosis and Haemostasis 71(1): 95-102
Gambhir, D.S.; Mukhopadhyay, S. 2000: Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions Indian Heart Journal 52(5): 524-532
Fujimoto, T.; Fujimura, K.; Kuramoto, A. 1990: Role of membrane glycoprotein (GP) IIb-IIIa complex on platelet Ca2+ ion influx Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 86: 34-43
Quinn, M.J.; Moliterno, D.J. 2002: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes Minerva Cardioangiologica 50(5): 547-553
Byzova, T.V.; Vlasik, T.N.; Mazurov, A.V. 1994: Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex Biulleten' Eksperimental'noi Biologii i Meditsiny 118(10): 402-405
Heras, M.; Escolar, G. 2000: Eptifibatide: a cyclic peptide that selectively inhibits platelet glycoprotein IIb/IIIa Drugs of Today 36(5): 295-311
Nishida, M.; Matsuno, H.; Kozawa, O.; Ueshima, S.; Matsuo, O.; Collen, D.; Uematsu, T. 2000: tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor Journal of Cardiovascular Pharmacology 36(6): 770-775
Adelman, A.G.; Caramori, P.R.; Cohen, E.A.; Chisholm, R.J.; Côté, G.; Ducas, J.; O'Neill, B.J.; Tcheng, J.E. 1998: The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era Canadian Journal of Cardiology 14(8): 1057-1066
López Cuéllar, J. 1999: Glycoprotein IIb/IIIa blockers. their usefulness in current cardiovascular therapeutics Archivos del Instituto de Cardiologia de Mexico 69(3): 272-281
Kessler, S.; Kessler, D.; Frishman, W.H. 1999: Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists Drugs of Today 35(6): 413-418